Xbox Game Pass is unquestionably worth the subscription fee, but which of the available games are the best use of your hard ...

From sexual innuendos to drug references, these controversial tracks caused such a stir that they were removed from the airwaves.

Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...

Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage trial are ...